SYMZIBEL Trademark

Trademark Overview

On Wednesday, February 5, 2020, a trademark application was filed for SYMZIBEL with the United States Patent and Trademark Office. The USPTO has given the SYMZIBEL trademark a serial number of 88785519. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, April 10, 2023. This trademark is owned by Vertex Pharmaceuticals Incorporated. The SYMZIBEL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for the treatment of cystic fibrosis
symzibel

General Information

Serial Number88785519
Word MarkSYMZIBEL
Filing DateWednesday, February 5, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, April 10, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 14, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for the treatment of cystic fibrosis

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSaturday, February 8, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameVertex Pharmaceuticals Incorporated
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBoston, MA 02210
Party NameVertex Pharmaceuticals Incorporated
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBoston, MA 02210

Trademark Events

Event DateEvent Description
Monday, April 10, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, April 10, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, August 24, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 22, 2022SOU EXTENSION 4 GRANTED
Monday, August 22, 2022SOU EXTENSION 4 FILED
Monday, August 22, 2022TEAS EXTENSION RECEIVED
Wednesday, July 27, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, July 27, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, July 27, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, July 27, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, March 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, March 4, 2022SOU EXTENSION 3 GRANTED
Friday, March 4, 2022SOU EXTENSION 3 FILED
Friday, March 4, 2022TEAS EXTENSION RECEIVED
Thursday, September 9, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 7, 2021SOU EXTENSION 2 GRANTED
Tuesday, September 7, 2021SOU EXTENSION 2 FILED
Tuesday, September 7, 2021TEAS EXTENSION RECEIVED
Friday, July 16, 2021ASSIGNED TO EXAMINER
Friday, February 12, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 10, 2021SOU EXTENSION 1 GRANTED
Wednesday, February 10, 2021SOU EXTENSION 1 FILED
Wednesday, February 10, 2021TEAS EXTENSION RECEIVED
Tuesday, September 8, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 14, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 14, 2020PUBLISHED FOR OPPOSITION
Wednesday, June 24, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 11, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 10, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, June 9, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, June 9, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, March 16, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, March 16, 2020NON-FINAL ACTION E-MAILED
Monday, March 16, 2020NON-FINAL ACTION WRITTEN
Monday, March 16, 2020ASSIGNED TO EXAMINER
Saturday, February 8, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, February 8, 2020NEW APPLICATION ENTERED

Related Keywords

symzibel fibrosis cystic treatment preparations pharmaceutical